3048SP |
Metribuzin, Serum/Plasma |
3057B |
Midazolam, Blood |
3057FL |
Midazolam, Fluid |
3057SP |
Midazolam, Serum/Plasma |
3057U |
Midazolam as Metabolite, Urine |
3111B |
Naloxone - Free (Unconjugated), Blood |
3111SP |
Naloxone - Free (Unconjugated), Serum/Plasma |
3111U |
Naloxone - Total (Conjugated/Unconjugated), Urine |
3113U |
Naloxone - Total (Conjugated/Unconjugated) Screen, Urine |
3116B |
Naltrexone and Metabolite - Free (Unconjugated), Blood |
3116SP |
Naltrexone and Metabolite - Free (Unconjugated), Serum/Plasma |
3116U |
Naltrexone and Metabolite - Total (Conjugated/Unconjugated), Urine |
3175B |
Nitrazepam and Metabolite, Blood |
3175SP |
Nitrazepam and Metabolite, Serum/Plasma |
3175U |
Nitrazepam and Metabolite, Urine |
3325B |
Paraquat, Blood |
3325SP |
Paraquat, Serum/Plasma |
3410B |
Pentobarbital, Blood |
3410SP |
Pentobarbital, Serum/Plasma |
3410U |
Pentobarbital, Urine |
3426B |
Perfluorooctanoic Acid, Blood Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3427SP |
Perfluoroalkyl Substances (PFAS), Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3428SP |
PFASure TM, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3429SP |
PFASure TM Expanded, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |